Table 1.

Clinical characteristics, initial symptoms, laboratory index, complications, and clinical outcomes of participants with COVID-19

Patient identifier	Sex	Age, y	Primary disease	Neutropenia during the week before initial symptoms	Initial symptoms					Laboratory		Complications						Outcomes
					Fever		Dry cough	Diarrhea	Muscle soreness	CRP	Lymphocytes	Dyspnea within 1 wk	Respiratory failure	Hypo tension shock	Liver dysfunction	Coagulation disorder	Secondary bacterial infection
					High	Mild/moderate	Dry cough	Diarrhea	Muscle soreness	CRP	Lymphocytes	Dyspnea within 1 wk	Respiratory failure	Hypo tension shock	Liver dysfunction	Coagulation disorder	Secondary bacterial infection
Patient 1	F	35	B-ALL	Yes	✓		✓			↑	—	✓			✓		✓	Recovery
Patient 2	M	31	B-ALL	Yes	✓		✓			↑	—	✓	✓	✓		✓ (DIC)	✓	Death
Patient 3	M	51	SAA	Yes	✓		✓			↑	—					✓	✓	Recovery
Patient 4	M	14	T-ALL	Yes	✓					↑	—	✓	✓	✓	✓	✓ (DIC)	✓	Death
Patient 5	F	54	MM	No	✓					↑	—	✓	✓	✓		✓ (DIC)	✓	Death
Patient 6	M	27	B-ALL	No			✓			↑	—							Recovery
Doctor 1	M	37	No	No		✓												Recovery
Nurse 1	F	29	No	No		✓		✓		↑	↓							Recovery
Nurse 2	F	25	No	No		✓	✓		✓		↓						✓	Recovery
Nurse 3	F	30	No	No		✓			✓	↑	↓							Recovery
Nurse 4	F	32	HT	No			✓											Recovery
Nurse 5	F	23	No	No		✓			✓									Recovery

—, lymphocyte variation of patients is not available for evaluation because of hematologic disease; B-ALL, acute B-lymphocytic leukemia; CRP, C-reactive protein; DIC, disseminated intravascular coagulation; F, female; HT, Hashimoto’s thyroiditis; M, male; MM, multiple myeloma; SAA, severe aplastic anemia; T-ALL, acute T-lymphocytic leukemia.